Imidazotriazines and imidazopyrimidines as kinase inhibitors
US7767675B2 · kind B2 · utility
33Cited by
5References
85Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2007 |
| Grant date | Aug 3, 2010 |
| Priority date | — |
| Expiry date | Nov 19, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.